<DOC>
	<DOCNO>NCT01066403</DOCNO>
	<brief_summary>The objective study compare modulation pergolide , D1/D2 receptor agonist , placebo non-acute schizophrenic subject concomitant therapy atypical antipsychotic specific PFC function . Further aim assess influence pergolide psychopathology extrapyramidal symptom comparison placebo .</brief_summary>
	<brief_title>Adjuvant Therapy With Pergolide Treating Cognitive Deficits Schizophrenia</brief_title>
	<detailed_description>Additionally desire treatment positive symptom , administration typical neuroleptic lead undesired side effect increase negative symptomatic cognitive deficit . The influence atypical neuroleptic cognition still well study . Furthermore evidence cognitive symptom see schizophrenia related disturbance prefrontal cortex PFC involve specific subtypes dopamine receptor , namely D1 subtypes , predominates area . It assume patient spectrum cognitive deficit bad course prognosis . Furthermore deficit therapy resistant conventional current therapy approach . There however evidence point positive influence dopamine agonists deficit , selective effect dopamine sub-receptors still well investigate . The aim study examine whether cognitive deficit higher cognitive function PFC work memory , semantic association executive control improve dopamine agonistic therapy schizophrenia whether related selective D1 modulation . We predict modulation D1 subtype receptor improve performance task . Because D1 agonist available human research decide use design compare dopamine agonist mixed D1 D2 agonistic property ( pergolide ) placebo stable D2 antagonistic continuous-therapy atypical antipsychotic . With design D2-component pergolide antagonize atypical antipsychotic D1 agonistic effect suggest , well protect patient psychotic re-exacerbation . With study aim bring insight therapy PFC cognitive deficit schizophrenia help elucidate role selective agonist cognition schizophrenic patient . I</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Pergolide</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<criteria>Nonacute outpatient , predominantly negative symptom , remit positive symptom like hallucination delusion 1 week , diagnosis schizophrenia ( ICD 10 : F20 ) Psychiatry Hospital Universities Heidelberg , HamburgEppendorf , Zentralinstitut f√ºr Seelische Gesundheit Mannheim , SRH Klinikum Karlsbad Langensteinbach ( Clinical interview establish diagnosis DSMIV ( M.I.N.I International Neuropsychiatric Interview _ German Version 5.0.0 ) Verbal IQ high 80 , measure MehrfachwahlWortschatzIntelligenztest Visual acuity must normal correct . Color sight intact Positive neuroleptic drug monitor level Females must adequate contraception ( oral hormonal contraceptive , IntraUterineDevice ) Concomitant neurologic internistic disease ( especially cardiovascular disease others like untreated thyroid hyper/hypofunction , liver kidney dysfunction , seizures history traumatic brain injury ) Known allergy reaction ergolinetherapy Actual history drug abuse/addiction , concomitant psychiatric disorder ( screened SCID ) suicide attempt medical history Other long term pharmacological treatment interact dopamine agonist antagonist ( e.g . anticoagulant , digitoxin ) Pregnancy breastfeed ( anamnesis pregnancy test urine ) Participation clinical trial last 3 month History malignant neuroleptic syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>cognitive deficit</keyword>
	<keyword>dopamine</keyword>
	<keyword>dopamine agonist</keyword>
	<keyword>prefrontal cortex</keyword>
	<keyword>D1 specific modulation</keyword>
	<keyword>pergolide</keyword>
	<keyword>executive control</keyword>
	<keyword>work memory</keyword>
	<keyword>Influence pergolide cognition Schizophrenia</keyword>
	<keyword>D1-specific modulation prefrontal function</keyword>
	<keyword>Influence pergolide psychopathology depression</keyword>
	<keyword>Influence pergolide extrapyramidal symptom</keyword>
</DOC>